TipRanks
AXXZIA, Inc. (JP:4936)
:4936
Japanese Market
Want to see JP:4936 full AI Analyst Report?

AXXZIA, Inc. (4936) AI Stock Analysis

1 Followers

Top Page

JP:4936

AXXZIA, Inc.

(4936)

Select Model
Select Model
Select Model
Neutral 51 (OpenAI - Gpt-5.6Sol)
Rating:51Neutral
Price Target:
¥315.00
▼(-3.08% Downside)
Action:Reiterated
Date:09/15/26
The score is held back mainly by the sharp profitability reversal to a 2026 loss and slowing top-line momentum, even though the balance sheet remains conservatively financed and free cash flow is still positive. Technicals also weigh on the rating, with the stock below major moving averages and bearish momentum, while valuation support comes primarily from the ~3.19% dividend yield despite a negative P/E.
Positive Factors
Low leverage
Very low leverage reduces financial risk and preserves flexibility during periods of weaker profitability. The sizable equity base provides additional protection against operating volatility, while limited debt obligations leave more capacity for investment, dividends, or recovery efforts.
Negative Factors
Profitability reversal
The move from strong profitability to negative operating profit and net income is a major deterioration in earnings quality. Unless margins recover, the loss reduces internally funded growth, raises dividend sustainability concerns, and weakens the company’s ability to absorb further cost pressure.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage
Very low leverage reduces financial risk and preserves flexibility during periods of weaker profitability. The sizable equity base provides additional protection against operating volatility, while limited debt obligations leave more capacity for investment, dividends, or recovery efforts.
Read all positive factors

AXXZIA, Inc. (4936) vs. iShares MSCI Japan ETF (EWJ)

AXXZIA, Inc. Business Overview & Revenue Model

Company Description
AXXZIA Inc. manufactures and sells cosmetics and supplements in Japan. The company offers eyecare, skincare, supplements and drinks, salon care, hair care, hair styling, and beauty device products under the AXXZIA, AGtheory, LisBeau, LisBlanc, The...

AXXZIA, Inc. Financial Statement Overview

Summary
Despite low leverage and consistently positive free cash flow, profitability deteriorated sharply, culminating in an operating loss and net loss in 2026 after stronger 2021–2024 results. Revenue growth also slowed/flattened in 2025–2026, increasing execution risk until margins stabilize.
Income Statement
41
Neutral
Balance Sheet
74
Positive
Cash Flow
62
Positive
BreakdownTTMJul 2026Jul 2025Jul 2024Jul 2023Jul 2022
Income Statement
Total Revenue13.29B13.47B13.48B12.19B11.34B8.22B
Gross Profit9.84B9.95B9.92B9.61B8.94B6.22B
EBITDA427.02M30.14M746.64M1.29B2.06B1.84B
Net Income173.18M-464.91M354.28M794.35M1.33B1.12B
Balance Sheet
Total Assets9.65B8.94B9.62B10.54B10.70B10.05B
Cash, Cash Equivalents and Short-Term Investments4.26B4.00B3.99B4.93B5.79B6.39B
Total Debt671.37M570.96M860.67M975.56M632.25M654.12M
Total Liabilities2.05B1.80B2.04B2.01B1.80B1.66B
Stockholders Equity7.60B7.14B7.57B8.53B8.90B8.40B
Cash Flow
Free Cash Flow0.00218.46M640.22M410.77M282.75M732.86M
Operating Cash Flow0.00298.86M781.65M800.36M707.85M797.69M
Investing Cash Flow0.00-106.92M-158.54M-626.66M-438.69M-775.36M
Financing Cash Flow0.00-452.29M-1.48B-1.55B-862.75M386.43M

AXXZIA, Inc. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price325.00
Price Trends
50DMA
323.68
Negative
100DMA
326.18
Negative
200DMA
347.14
Negative
Market Momentum
MACD
-5.08
Positive
RSI
37.14
Neutral
STOCH
42.79
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4936, the sentiment is Negative. The current price of 325 is above the 20-day moving average (MA) of 314.50, above the 50-day MA of 323.68, and below the 200-day MA of 347.14, indicating a bearish trend. The MACD of -5.08 indicates Positive momentum. The RSI at 37.14 is Neutral, neither overbought nor oversold. The STOCH value of 42.79 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4936.

AXXZIA, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
¥6.55B9.45―2.31%0.16%6.35%
73
Outperform
¥1.70B8.83―4.98%-6.17%-55.84%
65
Neutral
¥2.40B6.93―2.62%3.05%184.11%
65
Neutral
¥5.35B29.22―1.60%3.17%-27.27%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
53
Neutral
¥5.12B13.85――-14.09%-22.72%
51
Neutral
¥7.42B-15.05―3.27%-0.08%-246.12%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4936
AXXZIA, Inc.
306.00
-143.71
-31.96%
JP:4918
Ivy Cosmetics Corporation
301.00
-44.62
-12.91%
JP:4920
Nippon Shikizai, Inc.
1,130.00
8.25
0.74%
JP:4925
HABA Laboratories, Inc.
1,700.00
35.82
2.15%
JP:4926
C'BON COSMETICS Co., Ltd.
1,252.00
53.94
4.50%
JP:4934
Premier Anti-Aging Co., Ltd.
578.00
-217.00
-27.30%

AXXZIA, Inc. Corporate Events

AXXZIA Overhauls Governance With New Mandate-Based Executive Officer System
Jul 23, 2026
AXXZIA Inc. has resolved to introduce a mandate-based Executive Officer System to strengthen its corporate governance and better separate management oversight from business execution. The move replaces its existing employment-based executive offic...
AXXZIA Slashes FY2026 Earnings Outlook on China Slowdown and Rising Costs
Jun 18, 2026
AXXZIA Inc. has sharply revised its consolidated earnings forecast for the fiscal year ending July 31, 2026, cutting expected net sales and now projecting an operating loss instead of a profit, as profit attributable to owners of the parent is als...
AXXZIA Swings to Loss and Cuts Outlook but Maintains Dividend
Jun 18, 2026
AXXZIA reported net sales of ¥9.89 billion for the first three quarters of the fiscal year ending July 2026, a 1.9% decline year on year, and swung to an operating loss of ¥48 million as profits sharply deteriorated. Profit attributable ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 15, 2026